PHARMACEUTICAL COMBINATIONS FOR TREATMENT AND OF DIABETES MELLITUS

A pharmaceutical combination comprises (a) at least one enzymatic nitric oxide (NO) donor; (b) optionally at least one anti-diabetic ingredient; (c) additionally optionally a carrier; (d) and/or other auxiliaries. ACTIVITY : Antidiabetic; Nephrotropic; Neuroprotective; Ophthalmological; Cardiant; Ce...

Full description

Saved in:
Bibliographic Details
Main Authors SZILVASSY ZOLTAN DR, FERNINANDY PETER DR, TOSAKI ARPAD DR, KOVACS PETER DR, HERNADI FERENC DR, NEMETH JOZSEF DR, PANKUCSI CSABA DR
Format Patent
LanguageEnglish
Published 02.05.2007
Online AccessGet full text

Cover

More Information
Summary:A pharmaceutical combination comprises (a) at least one enzymatic nitric oxide (NO) donor; (b) optionally at least one anti-diabetic ingredient; (c) additionally optionally a carrier; (d) and/or other auxiliaries. ACTIVITY : Antidiabetic; Nephrotropic; Neuroprotective; Ophthalmological; Cardiant; Cerebroprotective; Antiinflammatory. MECHANISM OF ACTION : Platelet aggregation inhibitor, inhibitor of Ca 2> +> entry into cardiac myaytes, and inhibitor of catecholamine release from cardiac adrenergic nerve terminal.
Bibliography:Application Number: HUP0700127